British pharma contender GlaxoSmithKline ($GSK) is striving to regain relevance in a field long overshadowed by its rivals ...

GlaxoSmithKline has announced a $30 billion investment across US R&D and manufacturing over the next five years. Projects ...

GSK plans a $30 billion investment in US R&D and manufacturing, including $1.2 billion for advanced facilities and AI ...

The FDA reapproved a GSK drug that stopped being sold more than 25 years ago, as part of a push to identify potential ...

Leucovorin, also known as folinic acid, is a form of folate, an essential B vitamin, or B9. Leucovorin has been approved by ...

Drugmaker GSK said Wednesday it would invest $30 billion in U.S. research and development and supply chain infrastructure ...

UK-headquartered pharmaceutical company GSK has announced plans to spend $1.2bn on manufacturing facilities and digital ...

GSK plans to invest $30 billion on research, development and supply chain infrastructure in the U.S. over the next five years. The plan includes $1.2 billion for new manufacturing facilities and ...

Vaccine-maker Moderna has opened a new manufacturing base in Oxfordshire in a boost to the pharmaceutical industry after ...

GSK (NYSE:GSK) is making a massive bet on the U.S., saying it will invest at least $30 billion over the next five years to grow its research and supply chain footprint. The announcement came as ...

(Reuters) -On Monday, the U.S. Food and Drug Administration published a notice to the Federal Register ahead of a speech by ...